The store will not work correctly when cookies are disabled.
6-(4-Fluorophenyl)-2-phenylimidazo[1,2-a]pyridine
ID: ALA4440588
PubChem CID: 155514867
Max Phase: Preclinical
Molecular Formula: C19H13FN2
Molecular Weight: 288.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Fc1ccc(-c2ccc3nc(-c4ccccc4)cn3c2)cc1
Standard InChI: InChI=1S/C19H13FN2/c20-17-9-6-14(7-10-17)16-8-11-19-21-18(13-22(19)12-16)15-4-2-1-3-5-15/h1-13H
Standard InChI Key: QKFLIPOBCWMKNS-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
11.5466 -1.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5454 -2.3424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2535 -2.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9631 -2.3420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9603 -1.5193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2517 -1.1140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6680 -2.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6679 -3.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3754 -3.9744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3715 -2.3395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0796 -2.7432 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0865 -3.5617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8672 -3.8081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3427 -3.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8559 -2.4837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1585 -3.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5726 -3.8388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3890 -3.8321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7923 -3.1204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3733 -2.4139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5582 -2.4240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8388 -1.1145 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 7 2 0
4 7 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
14 16 1 0
1 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.32 | Molecular Weight (Monoisotopic): 288.1063 | AlogP: 4.81 | #Rotatable Bonds: 2 |
Polar Surface Area: 17.30 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.41 | CX LogP: 4.58 | CX LogD: 4.58 |
Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.52 | Np Likeness Score: -1.73 |
References
1. Quattrini L, Gelardi ELM, Coviello V, Sartini S, Ferraris DM, Mori M, Nakano I, Garavaglia S, La Motta C.. (2020) Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells., 63 (9): [PMID:32223240] [10.1021/acs.jmedchem.9b01910] |